Deepika Sirohi,
MD
No Rating Available?
0
out of
5
Patient Rating
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the
minimum.
Languages Spoken: English
Specialties
Board Certification and Academic Information
| Academic Departments | Pathology
-
Associate Professor (Clinical) |
| Academic Divisions | Anatomic Pathology |
| Board Certification | American Board of Pathology (Anatomic & Clinical) American Board of Pathology (Sub: Molecular Genetic Pathology) |
Academic Locations
Board Certification and Academic Information
| Academic Departments | Pathology
-
Associate Professor (Clinical) |
| Academic Divisions | Anatomic Pathology |
| Board Certification | American Board of Pathology (Anatomic & Clinical) American Board of Pathology (Sub: Molecular Genetic Pathology) |
Education History
| Fellowship | University of California, San Francisco Molecular Genetic Pathology Fellow, 2017 |
| Fellowship | Cedars-Sinai Medical Center Genitourinary Pathology Fellow, 2016 |
| Chief Resident | University of Texas Health Science Center at San Antonio Pathology Co-Chief Resident, 2015 |
| Residency | University of Texas Health Science Center at San Antonio Anatomic and Clinical Pathology Resident, 2014 |
| Professional Medical | Armed Forces Medical College Medicine, Pathology M.D., 2000 |
| Professional Medical | Armed Forces Medical College Medicine and Surgery M.B.B.S., 1993 |
Selected Publications - Journal Articles
Journal Article
- Wilcock DM, Sirohi D, Coleman JF, Gulbahce HE (2022). Digital imaging correlation of immunohistochemistry and fluorescence in situ hybridization in breast carcinoma cases with HER2 genetic heterogeneity. Hum Pathol, 126, 129-135.
- Wilcock DM, McMurtry V, Coleman JF, Kim JT, Khalili P, Deftereos G, Albertson D, Gulbahce EH, Liu T, Sirohi D (2022). Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms. Int J Surg Pathol, 10668969221085289.
- Wilcock DM, Schmidt RL, Furtado LV, Matynia AP, Deftereos G, Sirohi D (2021). Histologic and Molecular Characterization of Non-Small Cell Lung Carcinoma With Discordant ROS1 Immunohistochemistry and Fluorescence In Situ Hybridization. Appl Immunohistochem Mol Morphol, 30(1), 19-26.
- Maughan BL, Kessel A, McFarland TR, Sayegh N, Nussenzveig R, Hahn AW, Hoffman JM, Morton K, Sirohi D, Kohli M, Swami U, Boucher K, Haaland B, Agarwal N (2021). Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. Oncologist, 26(12), 1006-e2129.
- Jedrzkiewicz J, Sirohi D, Uvejzovic N, Gulbahce HE (2021). RAI1 alternate probe identifies additional gastroesophageal adenocarcinoma cases as amplified following equivocal HER2 fluorescence in situ hybridization testing: experience from a national reference laboratory. Mod Pathol, 35, 549-553.
- Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, Baras AS, DeMarzo AM, Cheville JC, Jimenez RE, Trpkov K, Colecchia M, Ro JY, Montironi R, Menon S, Hes O, Williamson SR, Hirsch MS, Netto GJ, Fine SW, Sirohi D, Kaushal S, Sangoi A, Robinson BD, Kweldam CF, Humphrey PA, Hansel DE, Schultz L, Magi-Galluzzi C, Przybycin CG, Shah RB, Mehra R, Kunju LP, Aron M, Kryvenko ON, Kench JG, Kuroda N, Tavora F, van der Kwast T, Grignon DJ, Epstein JI, Reuter VE, Amin MB (2019). Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Am J Surg Pathol, 44(5), 673-680.
- Sirohi D, Schmidt RL, Aisner DL, Behdad A, Betz BL, Brown N, Coleman JF, Corless CL, Deftereos G, Ewalt MD, Fernandes H, Hsiao SJ, Mansukhani MM, Murray SS, Niu N, Ritterhouse LL, Suarez CJ, Tafe LJ, Thorson JA, Segal JP, Furtado LV (2019). Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer. J Mol Diagn, 22(2), 284-293.
- Hahn AW, Sirohi D, Agarwal N (2019). The Role of PD-L1 Testing in Advanced Genitourinary Malignancies. Eur Urol Focus, 6(1), 11-13.
- Lin L, Sirohi D, Coleman JF, Gulbahce HE (2019). American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory. Am J Clin Pathol, 152(4), 479-485.
Review
- Hamza A, Sirohi D, Smith SC, Amin MB (2021). Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors. [Review]. Adv Anat Pathol, 28(6), 396-407.
- Sirohi D MD, Ohe C, Smith SC, Amin MB (2021). SWI/SNF-deficient neoplasms of the genitourinary tract. [Review]. Semin Diagn Pathol, 38(3), 212-221.
Letter
Other
- Sirohi D, Chipman J, Barry M, Albertson D, Mahlow J, Liu T, Raps E, Haaland B, Sayegh N, Li H, Rathi N, Sharma P, Agarwal N, Knudsen B (2022). Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups. Clin Genitourin Cancer (20(3), pp. e233-e243). United States.
- Lin E, Hahn AW, Nussenzveig RH, Wesolowski S, Sayegh N, Maughan BL, McFarland T, Rathi N, Sirohi D, Sonpavde G, Swami U, Kohli M, Rich T, Sartor O, Yandell M, Agarwal N (2021). Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. Oncologist (26(9), pp. 751-760). United States.
Global Impact
Education History
| Professional Medical | Armed Forces Medical College Medicine, Pathology M.D. |
| Professional Medical | Armed Forces Medical College Medicine and Surgery M.B.B.S. |